Nouveau? Inscrivez-vous

Client Existant: Connexion


You can contact us by live chat,
email or telephone.

Acomplia

This weight loss product has been suspended

Europe wide suspension of Marketing Authorisation for Acomplia (rimonabant)

Current patient information and advice:

Acomplia will no longer be available within the EU and Prima-med has now suspended all prescriptions for Acomplia. The MHRA has not issued official instructions asking patients, currently taking Acomplia, to stop, however patients who wish to stop taking Acomplia can do so at any time. If you would like more information please do not hesitate to contact our doctor.

As with any new treatment you are bound to have many questions about Acomplia, especially whether or not there are any Acomplia side effects you need to be aware of. Listed below are common questions and answers designed to provide first time guidance regarding the Acomplia that is currently available with our service. If there is a question you would like to put to our doctor that is not covered below, please feel free to email doctor@prima-med.com.

to view MHRA advice

http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON028547

Here are the important things you need to know before you choose the Weight loss medication, Acomplia

 

What is Acomplia?

Acomplia is a new prescription weight loss drug. Acomplia tablets contain the active ingredient rimonabant, which is a type of medicine called a cannabinoid-1 receptor antagonist.

Back to top

How does Acomplia work?

Acomplia ( rimonabant) works by blocking receptors called cannabinoid-1 receptors (CB1). These are found in the brain, fat tissue, digestive system, liver and muscles. Rimonabant blocks CB1 receptors and so reduces cravings for food and helps decrease appetite and control hunger.

Note: During clinical studies the drug clearly demonstrated a reduced craving for nicotine in patients the drug has only at the moment been approved as an obesity treatment.

Back to top

How well does Acomplia work?

A 20mg dose of Acomplia statistically significantly:

  • Reduces weight
  • Improves blood sugar levels
  • Improves the blood lipid profile
  • Improves systolic blood pressure

Acomplia has also been shown to have a beneficial effect on blood glucose and fat levels. Specifically it raises HDL cholesterol levels (the good cholesterol).

Back to top

What is the correct dosage?

The usual dose is one 20mg tablet to be taken once daily in the morning before breakfast. Swallow the tablet whole.

You need to start and continue a reduced calorie diet and a physical activity program to get best results. Your doctor should recommend the type of diet and the level of physical activity required, that suits your specific condition and overall health.

Back to top

What are the side effects of Acomplia?

It has been reported by some that some of the side effects seem to subside once adjustment to the drug is made. Possible side-effects include:

  • Nausea and vomiting
  • Disorders of the nervous system, this includes headaches, faintness and feeling dizzy.
  • Psychiatric disorders, including mood swings, anxiety, depression, irritability, sleep disorders and other similar disorders. If you already have a history of mental health disorders, it would be highly advisable to mention this to your doctor before obtaining this drug.
Back to top

Is there any reason why I shouldn't take Acomplia?

Acomplia is only licensed for weight control in patients with a BMI (Body Mass Index) above 30 or Patients with a BMI above 27 with associated risk factor(s), such as type 2 diabetes or dyslipidaemia.

Acomplia should not be taken, or should be taken only under exceptional circumstances under your doctor's direct guidance, in the following circumstances:

  • Anyone who exhibits hypersensitivity or an allergic reaction to the drug (it should never be used in these circumstances).
  • Anyone with an impaired liver function. The effects of Acomplia have not been studied in patients with liver damage.
  • Anyone with impaired kidney function. It should never be used in patients with a severely limited kidney function.
  • Anyone over the age of 75. There is no data currently available to establish safety in this age group.
  • Any children under the age of 18. There is currently a lack of data on efficacy and safety for this age group.
  • Pregnant or lactating women; safety in these groups has not been established. Indeed, current data in rats shows possible damage to the developing foetus and an inhibited sucking reflex in young rats.
  • There is little data on the safety of Acomplia in patients suffering from epilepsy and it should be prescribed with caution in these instances.
  • The Acomplia tablet contains lactose and should therefore not be prescribed to patients with a lactose intolerance.
  • It should only be used with caution in combination with CYP3A4 inhibitors, such as ketocinazole, ritonavir, clarthromycin and related drugs.
  • It should not be prescribed to patients with an uncontrolled psychiatric condition, and is not recommended for use with antidepressants as there is a lack of data on the safety in these circumstances. Acomplia may bring about an increased incidence of suicidal thoughts and is not recommended for patients who are clinically depressed.

Register to order alternative weight loss treatments